Estrella Immunopharma, Inc.
ESLA
$0.64
$0.00-0.36%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -88.86% | 357.27% | 50.98% | -- | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 923.79% | -56.04% | -59.57% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 23.25% | 128.44% | 2.21% | -9.47% | -66.76% |
|
|
|||||
| Total Current Assets | 23.25% | 128.44% | 2.21% | -9.47% | -66.76% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 0.00% | 0.00% | -- | -- |
| Total Assets | -38.78% | 49.62% | 1.15% | -5.67% | -33.09% |
|
|
|||||
| Total Accounts Payable | 0.00% | 6.43% | 12,509.09% | -- | -- |
| Total Accrued Expenses | -3.56% | 98.82% | 323.35% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 50.00% | -- | -- |
| Total Finance Division Other Current Liabilities | 266.31% | 14,042.42% | 3,407.48% | -- | -- |
| Total Other Current Liabilities | 266.31% | 14,042.42% | 3,407.48% | -- | -- |
| Total Current Liabilities | 1.99% | 108.82% | 351.89% | 346.98% | 4,922.25% |
|
|
|||||
| Total Current Liabilities | 1.99% | 108.82% | 351.89% | 346.98% | 4,922.25% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.99% | 108.82% | 351.89% | 346.98% | 4,922.25% |
|
|
|||||
| Common Stock & APIC | 33.27% | 39.57% | 10.48% | -- | -- |
| Retained Earnings | -31.71% | -50.90% | -54.60% | -59.01% | -61.93% |
| Treasury Stock & Other | 0.00% | 0.00% | -5.19% | -- | -- |
| Total Common Equity | -21.93% | -187.85% | -7,313.71% | -1,418.02% | -242.62% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -21.93% | -187.85% | -7,313.71% | -1,418.02% | -242.62% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -21.93% | -187.85% | -7,313.71% | -- | -- |
|
|
|||||